Biocon’s subsidiary Biocon Pharma has received the Food and Drug Administration’s permission for norepinephrine bitartrate injection (4 mg/4 ml, 1 mg/ml) in a single-dose vial, the company said in a ...

First and only manufacturer-prepared premix formulation of norepinephrine available Offers variety of storage options under refrigeration and at room temperature, allowing drug to be placed closer to ...

Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to ...

Long Grove Pharmaceuticals announced the strategic in-licensing of norepinephrine in 0.9% sodium chloride premix formulation from Nevakar Injectables. This manufactured, ready-to-use formulation is ...

Norepinephrine is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states. Baxter International has announced the commercial launch of premix ...

A new option for manufactured Premix Norepinephrine Bitartrate in 0.9% Sodium Chloride will help meet supply reliability and patient safety needs ROSEMONT, Ill., May 4, 2023 /PRNewswire/ -- Long Grove ...

Baxter International Inc. BAX recently announced the receipt of the FDA’s approval and commercial launch of premix (ready-to-use) Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine).